ஜர்னல் ஆஃப் அப்ளைடு பார்மசி
திறந்த அணுகல்

சுருக்கம்

The Latest Advances of Pharmacotherapy for COVID-19

Rebacca Smith

COVID-19, also known as SARS-CoV-2, has been described as one of the most dangerous virus outbreaks in human history. It has been impacting worldwide health since its appearance in December 2019, with no documented pharmacotherapeutic drug that can neutralise its significant pathogenicity and escalation over the world. This is due to the extraordinary chemical pathways it uses during its life cycle, which takes place in and around the host cell. The virus may successfully infiltrate and reproduce in the host cell thanks to these developed processes. Following a thorough examination of the life cycle, various molecular targets that can be neutralised with the use of pharmacotherapeutic drugs have been identified. These agents bind to their targets and render them inactive.